BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20563250)

  • 21. Bmi-1 over-expression in neural stem/progenitor cells increases proliferation and neurogenesis in culture but has little effect on these functions in vivo.
    He S; Iwashita T; Buchstaller J; Molofsky AV; Thomas D; Morrison SJ
    Dev Biol; 2009 Apr; 328(2):257-72. PubMed ID: 19389366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation.
    Zheng H; Ying H; Yan H; Kimmelman AC; Hiller DJ; Chen AJ; Perry SR; Tonon G; Chu GC; Ding Z; Stommel JM; Dunn KL; Wiedemeyer R; You MJ; Brennan C; Wang YA; Ligon KL; Wong WH; Chin L; DePinho RA
    Nature; 2008 Oct; 455(7216):1129-33. PubMed ID: 18948956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCCRO (DCUN1D1) induces extracellular matrix invasion by activating matrix metalloproteinase 2.
    O-charoenrat P; Sarkaria I; Talbot SG; Reddy P; Dao S; Ngai I; Shaha A; Kraus D; Shah J; Rusch V; Ramanathan Y; Singh B
    Clin Cancer Res; 2008 Nov; 14(21):6780-9. PubMed ID: 18980971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma.
    Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB
    Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas.
    Calogero A; Arcella A; De Gregorio G; Porcellini A; Mercola D; Liu C; Lombari V; Zani M; Giannini G; Gagliardi FM; Caruso R; Gulino A; Frati L; Ragona G
    Clin Cancer Res; 2001 Sep; 7(9):2788-96. PubMed ID: 11555594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-656 inhibits glioma tumorigenesis through repression of BMPR1A.
    Guo M; Jiang Z; Zhang X; Lu D; Ha AD; Sun J; Du W; Wu Z; Hu L; Khadarian K; Shen J; Lin Z
    Carcinogenesis; 2014 Aug; 35(8):1698-706. PubMed ID: 24480809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma.
    Põlajeva J; Swartling FJ; Jiang Y; Singh U; Pietras K; Uhrbom L; Westermark B; Roswall P
    BMC Cancer; 2012 Aug; 12():378. PubMed ID: 22931209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative expression analysis reveals lineage relationships between human and murine gliomas and a dominance of glial signatures during tumor propagation in vitro.
    Henriquez NV; Forshew T; Tatevossian R; Ellis M; Richard-Loendt A; Rogers H; Jacques TS; Reitboeck PG; Pearce K; Sheer D; Grundy RG; Brandner S
    Cancer Res; 2013 Sep; 73(18):5834-44. PubMed ID: 23887970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Loss of Arf causes tumor progression of PDGFB-induced oligodendroglioma.
    Tchougounova E; Kastemar M; Bråsäter D; Holland EC; Westermark B; Uhrbom L
    Oncogene; 2007 Sep; 26(43):6289-96. PubMed ID: 17438529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma.
    Hu X; Pandolfi PP; Li Y; Koutcher JA; Rosenblum M; Holland EC
    Neoplasia; 2005 Apr; 7(4):356-68. PubMed ID: 15967113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA double-strand breaks cooperate with loss of Ink4 and Arf tumor suppressors to generate glioblastomas with frequent Met amplification.
    Camacho CV; Todorova PK; Hardebeck MC; Tomimatsu N; Gil del Alcazar CR; Ilcheva M; Mukherjee B; McEllin B; Vemireddy V; Hatanpaa K; Story MD; Habib AA; Murty VV; Bachoo R; Burma S
    Oncogene; 2015 Feb; 34(8):1064-72. PubMed ID: 24632607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Squamous cell carcinoma related oncogene regulates angiogenesis through vascular endothelial growth factor-A.
    Talbot SG; O-charoenrat P; Sarkaria IS; Ghossein R; Reddy P; Ngai I; Cordeiro CN; Wong RJ; Kris MG; Rusch VW; Singh B
    Ann Surg Oncol; 2004 May; 11(5):530-4. PubMed ID: 15123463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SCCRO (DCUN1D1) promotes nuclear translocation and assembly of the neddylation E3 complex.
    Huang G; Kaufman AJ; Ramanathan Y; Singh B
    J Biol Chem; 2011 Mar; 286(12):10297-304. PubMed ID: 21247897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
    Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
    BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamous cell carcinoma-related oncogene (SCCRO) neddylates Cul3 protein to selectively promote midbody localization and activity of Cul3
    Huang G; Kaufman AJ; Xu K; Manova K; Singh B
    J Biol Chem; 2017 Sep; 292(37):15254-15265. PubMed ID: 28620047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Constitutive activation of Raf-1 induces glioma formation in mice.
    Lyustikman Y; Momota H; Pao W; Holland EC
    Neoplasia; 2008 May; 10(5):501-10. PubMed ID: 18472967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bcl-2 promotes malignant progression in a PDGF-B-dependent murine model of oligodendroglioma.
    Doucette T; Yang Y; Zhang W; Fuller GN; Suki D; Fults DW; Rao G
    Int J Cancer; 2011 Nov; 129(9):2093-103. PubMed ID: 21171016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology Group.
    Pollack IF; Hamilton RL; Burger PC; Brat DJ; Rosenblum MK; Murdoch GH; Nikiforova MN; Holmes EJ; Zhou T; Cohen KJ; Jakacki RI;
    J Neurooncol; 2010 Sep; 99(2):155-63. PubMed ID: 20607350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glioma initiating cells contribute to malignant transformation of host glial cells during tumor tissue remodeling via PDGF signaling.
    Chen Y; Wang Z; Dai X; Fei X; Shen Y; Zhang M; Wang A; Li X; Wang Z; Huang Q; Dong J
    Cancer Lett; 2015 Sep; 365(2):174-81. PubMed ID: 26049020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic driver mutations define the expression signature and microenvironmental composition of high-grade gliomas.
    Herting CJ; Chen Z; Pitter KL; Szulzewsky F; Kaffes I; Kaluzova M; Park JC; Cimino PJ; Brennan C; Wang B; Hambardzumyan D
    Glia; 2017 Dec; 65(12):1914-1926. PubMed ID: 28836293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.